The neurobiology of addiction: Where we have been and where we are going

Journal of Drug Issues

Volumn 39, Issue 3, 2009, Pages 759-776

  Koob, George F ^a   Simon, Eric J ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70449372224     PISSN: 00220426     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Evans, C., Keith, D., Morrison, H., Magendzo, K., & Edwards, R. 1992 Cloning of a delta-opioid receptor by functional expression. Science, 258, 1952-1955.
2. Gioannini, T. L., Fan, L. Q., Hyde, L., Ofri, D., Yao, Y., Hiller, J. M., & Simon, E. J. 1993 Reconstitution of a purified mu-opioid binding protein in liposomes: Selective, high affinity, GTP-gamma S-sensitive mu-opioid agonist binding is restored. Biochemical and Biophysical Research Communications, 194, 901-908.
3. Gioannini, T. L., Howard, A. D., Hiller, J. M., & Simon, E. J. 1985 Purification of an active opioid binding protein from bovine striatum. Journal of Biological Chemistry, 260, 15117-15121.
4. Heilig, M., Koob, G. F., Ekman, R., & Britton, K. T. 1994 Corticotropin-releasing factor and neuropeptide Y: Role in emotional integration. Trends in Neurosciences, 17, 80-85.
5. Heinrichs, S. C., & Koob, G. F. 2004 Corticotropin-releasing factor in brain: A role in activation, arousal, and affect regulation. Journal of Pharmacology and Experimental Therapeutics, 311, 427-440.
6. Kieffer, B., Befort, K., Ruff, C., & Hirth, C. 1992 The delta-opioid receptor: Isolation of a cDNA by expression cloning and pharmacological characterization. Proceedings of the National Academy of Sciences USA, 89, 12048-12052.
7. Kieffer, B., & Gaveriaux-Ruff, C. 2002 Exploring the opioid system by gene knockout. Progress in Neurobiology, 66, 285-306.
8. Koob, G. F. 1992 Drugs of abuse: Anatomy, pharmacology, and function of reward pathways. Trends in Pharmacological Sciences, 13, 177-184
9. Koob, G. F. 2003 Neuroadaptive mechanisms of addiction: Studies on the extended amygdala. European Neuropsychopharmacology, 13, 442-452.
10. Koob, G. F. 2004 Allostatic view of motivation: Implications for psychopathology. In R. A. Bevins & M. T. Bardo (Eds.), Motivational factors in the etiology of drug abuse (series title: Nebraska symposium on motivation, vol. 50) (pp. 1-18). Lincoln NE: University of Nebraska Press.
11. Koob, G. F. 2008 A role for brain stress systems in addiction. Neuron, 59, 11-34.
12. Koob, G. F., & Le Moal, M. 2001 Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology, 24, 97-129.
13. Koob, G. F., & Le Moal, M. 2005 Plasticity of reward neurocircuitry and the 'dark side' of drug addiction. Nature Neuroscience, 8, 1442-1444.
14. Koob, G. F., & Le Moal, M. 2006 Neurobiology of addiction. London: Academic Press.
15. Koob, G. F., & Le Moal, M. 2008 Addiction and the brain antireward system. Annual Review of Psychology, 59, 29-53.
16. Koob, G. F., Sanna, P. P., & Bloom, F. E. 1998 Neuroscience of addiction. Neuron, 21, 467-476.
17. Kramer, H. K., Andria, M. L., Esposito, D. H., & Simon, E. J. 2000 Tyrosine phosphorylation of the delta-opioid receptor: Evidence for its role in mitogen-activated protein kinase activation and receptor internalization. Biochemical Pharmacology, 60, 781-792.
18. McFarland, K., & Kalivas, P. W. 2001 The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior. Journal of Neuroscience, 21, 8655-8663.
19. Noda, M., Teranishi, Y., Takahashi, H., Toyosato, M., Notake, M., Nakanishi, S., & Numa, S. 1982 Isolation and structural organization of the human preproenkephalin gene. Nature, 297, 431-434.
20. Pak, Y., O'Dowd, B. F., Wang, J. B., & George, S. R. 1999 Agonist-induced, G protein-dependent and -independent down-regulation of the mu opioid receptor. The receptor is a direct substrate for proteintyrosine kinase. Journal of Biological Chemistry, 274, 27610-27616.
21. Pert, C. B., & Snyder, S. H. 1973 Opiate receptor: Demonstration in nervous tissue. Science, 179, 1011-1014.
22. Schiffer, C. A. 2007 BCR-ABL tyrosine kinase inhibitors for chronic myelogenous leukemia. New England Journal of Medicine, 357, 258-265.
23. Shaham, Y., Shalev, U., Lu, L., De Wit, H., & Stewart, J. 2003 The reinstatement model of drug relapse: History, methodology and major findings. Psychopharmacology, 168, 3-20.
24. Shippenberg, T. S., & Koob, G. F. 2002 Recent advances in animal models of drug addiction and alcoholism. In K. L. Davis, D. Charney, J. T. Coyle, & C. Nemeroff, (Eds.), Neuropsychopharmacology: The fifth generation of progress (pp. 1381-1397). Philadelphia: Lippincott Williams and Wilkins.
25. Simon, E. J., & Hiller, J. M. 1994 Opioid peptides and opioid receptors. In G. J. E. A. Siegel, (Eds.), Basic neurochemistry: Molecular, cellular, and medical aspects (pp. 321-339). New York: Raven Press.
26. 3H]etorphine to rat brain homogenate. Proceedings of the National Academy of Sciences USA, 70, 1947-1949.
27. Terenius, L. 1973 Stereospecific interaction between narcotic analgesics and a synaptic plasma membrane fraction of rat cerebral cortex. Acta Pharmacoligica Toxicoligica, 32, 317-320.
28. Volkow, N. D., & Fowler, J. S. 2000 Addiction, a disease of compulsion and drive: Involvement of the orbitofrontal cortex. Cerebral Cortex, 10, 318-325.
29. Volkow, N. D., & Li, T. K. 2004 Drug addiction: The neurobiology of behavior gone awry. Nature Reviews Neuroscience, 5, 963-970.
30. Wise, R. A. 1980 Action of drugs of abuse on brain reward systems. Pharmacology Biochemistry and Behavior, 13 (Suppl 1), 213-223.